)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Enzymatica
Enzymatica (ENZY) investor relations material
Enzymatica Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary28 Apr, 2026
Executive summary
Net sales for Q1 2026 were SEK 11.4 million, a 6.8% decrease year-over-year, mainly due to a milder cold season in Sweden and no partner sales recorded during the quarter.
Operating loss improved to SEK -13.6 million from SEK -18.0 million in Q1 2025, reflecting better cost discipline and reduced expenses.
A major partnership with STADA was signed to launch ColdZyme in Germany and Austria, expected to impact sales from the 2026/2027 cold season.
The company is prioritizing international expansion, partnerships, and brand development, with ongoing partner discussions in Europe, the Middle East, and Latin America.
Financial highlights
Net sales: SEK 11.4 million (Q1 2025: SEK 12.3 million).
Gross margin: 56% (Q1 2025: 69%), impacted by higher manufacturing partner costs.
Operating loss: SEK -13.6 million (Q1 2025: SEK -18.0 million).
Earnings per share: SEK -0.06 (Q1 2025: SEK -0.07).
Net cash at period end: SEK 25.4 million (Q1 2025: SEK 64.7 million).
Outlook and guidance
The STADA partnership is expected to drive growth in Germany and Austria, with commercial impact from the 2026/2027 season.
The Board is reviewing financial targets, with updated guidance to be presented later in 2026.
Focus remains on sustainable, profitable growth through partnerships and international expansion.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Enzymatica
- International expansion and key partnerships drive growth for a clinically proven cold remedy.ENZY
Stora Aktiedagarna 202610 Mar 2026 - Net sales rose 18.3% and ColdZyme gained market share, while losses narrowed and expansion accelerated.ENZYQ4 202518 Feb 2026
- ColdZyme cut rhinovirus viral load by 94% and eased cold symptoms in new studies.ENZYStudy Result2 Dec 2025
- Net sales up 25.2% and ColdZyme gains market share, but losses persist amid higher costs.ENZYQ3 202530 Oct 2025
- Net sales surged 29% year-over-year, driven by ColdZyme's strong growth and new partnerships.ENZYQ2 202517 Jul 2025
- Sales fell but gross margin and cash position improved; rights issue boosts expansion plans.ENZYQ3 202413 Jun 2025
- Sales declined and losses widened, but new funding and clinical data may drive future growth.ENZYQ2 202413 Jun 2025
- Sales up 30% and ColdZyme's efficacy confirmed, supporting global expansion plans.ENZYQ1 20255 Jun 2025
- Core market growth and strong cash position set stage for ColdZyme's 2025 expansion.ENZYQ4 20245 Jun 2025
Next Enzymatica earnings date
Q2 202616 Jul, 2026
Enzymatica
Next Enzymatica earnings date
Q2 202616 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage